Market Data 
Markets
Replies to post #183938 on Biotech Values
11/17/14 2:46 PM
11/20/14 12:02 PM
12/25/14 11:07 AM
J.P. Morgan Chase & Co. represented Actavis, which swooped in and saved Allergan from a protracted hostile takeover battle with Valeant Pharmaceutical International. For its work, J.P. Morgan’s bankers earned $65 million in fees… That payout…ties the $65 million Morgan Stanley earned for advising Wyeth on its $68 billion sale to Pfizer in 2009.
Meanwhile, Allergan’s bankers, which spent more than six months fighting off Valeant this year, earned $112.2 million in total with Goldman Sachs Group and Bank of America Merrill Lynch each taking home $56.1 million.
DealPoint Data adds together the amounts being paid to each bank to count them as the single largest fee for an M&A target’s advisers in its database.
01/26/15 8:42 AM
Actavis plc…and the owners of Auden Mckenzie Holdings Limited…today announced that they have reached a definitive agreement, under which Actavis will acquire Auden Mckenzie for approximately £306 million in cash, plus a two-year royalty on a percentage of gross profits of one of Auden Mckenzie's products.
03/17/15 12:29 PM
AI
